Mary Morrow
Overview
Explore the profile of Mary Morrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coyle R, Morrow M, Mann S, Mainella V, Ellis S, Schwab S, et al.
Clin Infect Dis
. 2024 Apr;
79(5):1233-1241.
PMID: 38636950
Background: QUANTI-TAF aimed to establish tenofovir-diphosphate (TFV-DP)/emtricitabine-triphosphate (FTC-TP) adherence benchmarks in dried blood spots (DBS) for persons with human immunodeficiency virus (PWH) receiving tenofovir alafenamide/emtricitabine (TAF/FTC)-based antiretroviral therapy (ART). Methods:...
2.
Erlandson K, Mohaweche R, Morrow M, MaWhinney S, Khuu V, Boyd M, et al.
J Antimicrob Chemother
. 2023 Nov;
79(1):179-185.
PMID: 38000089
Background: Integrase strand transfer inhibitors (INSTIs) are associated with excessive weight gain among a subset of persons with HIV (PWH), due to unclear mechanisms. We assessed energy intake (EI) and...
3.
Hirsh M, Edwards J, Robichaux C, Brijkumar J, Moosa M, Ofotokun I, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad360.
PMID: 37469618
Background: Food insecurity has been linked to suboptimal antiretroviral therapy (ART) adherence in persons with HIV (PWH). This association has not been evaluated using tenofovir diphosphate (TFV-DP) in dried blood...
4.
Mainella V, Morrow M, Brooks K, Bushman L, Abdelmawla F, Nerguizian D, et al.
AIDS Res Hum Retroviruses
. 2023 Jun;
40(5):227-230.
PMID: 37382422
The purpose of this study was to evaluate the relationship between intracellular islatravir-triphosphate (ISL-TP) in paired peripheral blood mononuclear cells (PBMCs) and dried blood spots (DBS). Three pig-tailed macaques (PMs)...
5.
Castillo-Mancilla J, Morrow M, Hunt P, Schnittman S, Phillips A, Baker J, et al.
Open Forum Infect Dis
. 2023 May;
10(5):ofad230.
PMID: 37213424
Background: Incomplete antiretroviral therapy (ART) adherence has been linked to deleterious immunologic, inflammatory, and clinical consequences, even among virally suppressed (<50 copies/mL) persons with human immunodeficiency virus (PWH). The impact...
6.
Churchill L, Morrow M, Capin J, Jolley S, Hare K, MaWhinney S, et al.
JMIR Rehabil Assist Technol
. 2023 Mar;
10:e43436.
PMID: 36939818
Background: Knowledge on physical activity recovery after COVID-19 survival is limited. The AFTER (App-Facilitated Tele-Rehabilitation) program for COVID-19 survivors randomized participants, following hospital discharge, to either education and unstructured physical...
7.
Morrow M, MaWhinney S, Brooks K, Huntley R, Castillo-Mancilla J, Anderson P, et al.
Contemp Clin Trials
. 2022 Dec;
125:107051.
PMID: 36528338
Ambiguous adherence data adversely effects the statistical analyses, study conclusions, and generalizability of research findings for clinical trials. Fortunately, technology-based measures of drug dosing provide more objective measures of medication...
8.
Grinsteiner E, Morrow M, MaWhinney S, Coyle R, Coleman S, Zheng J, et al.
AIDS Res Hum Retroviruses
. 2022 Oct;
39(1):33-37.
PMID: 36301917
The potency of modern antiretroviral therapy (ART) allows for greater forgiveness to missed doses while still achieving, and maintaining, viral suppression. However, imperfect ART adherence, even if sufficient to maintain...
9.
Capin J, Jolley S, Morrow M, Connors M, Hare K, MaWhinney S, et al.
BMJ Open
. 2022 Jul;
12(7):e061285.
PMID: 35882451
Objectives: Determine the safety, feasibility and initial efficacy of a multicomponent telerehabilitation programme for COVID-19 survivors. Design: Pilot randomised feasibility study. Setting: In-home telerehabilitation. Participants: 44 participants (21 female, mean...
10.
Coyle R, Morrow M, MaWhinney S, Coleman S, Zheng J, Ellison L, et al.
Pharmacotherapy
. 2022 Jun;
42(8):641-650.
PMID: 35707973
Background: We assessed cumulative antiretroviral exposure-using tenofovir diphosphate (TFV-DP) in dried blood spots (DBS)-in persons with HIV (PWH) receiving tenofovir disoproxil fumarate (TDF)-based antiretroviral therapy (ART) as single-tablet regimens (STR)...